A 96-well single-pot liquid-liquid extraction, hydrophilic interaction liquid chromatography-mass spectrometry method for the determination of muraglitazar in human plasma

被引:26
作者
Xue, Y. -J. [1 ]
Liu, Jane [1 ]
Unger, Steve [1 ]
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Preclin Candidate Optimizat, New Brunswick, NJ 08903 USA
关键词
single-pot; liquid-liquid extraction; hydrophilic interaction liquid chromatography; LC/MS/MS; muraglitazar;
D O I
10.1016/j.jpba.2006.02.006
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A single-pot liquid-liquid extraction (LLE) with hydrophilic interaction liquid chromatography/tandem mass spectrometry (HILIC/MS/MS) method has been developed and validated for the determination of muraglitazar, a hydrophobic diabetes drug, in human plasma. To 0.050 ml of each plasma sample in a 96-well plate, the internal standard solution in acetonitrile and toluene were added to extract the compound of interest. The plate was vortexed, followed by centrifugation. The organic layer was then directly injected into an LC/MS/MS system. Chromatographic separation was achieved isocratically on a Thermohypersil_Keystone, Hypersil silica column (3 mm x 50 mm, 3 mu m). The mobile phase contained 85% of methyl t-butyl ether and 15% of 90/10 (v/v) acetonitrile/water with 0.3% trifluoroacetic acid. Post-column mobile phase of 50150 (v/v) acetonitrile/water containing 0.1% formic acid was added. Detection was by positive ion electrospray tandem mass spectrometry on a Sciex API 4000. The standard curve, ranged from 1 to 1000 ng/ml, was fitted to a 1/x weighted quadratic regression model. This single-pot LLE approach effectively eliminated time-consuming organic layer transfer, dry-down, and sample reconstitution steps, which are essential for a conventional liquid-liquid extraction procedure. The modified mobile phase was more compatible with the direct injection of the commonly used extraction solvents in LLE. Furthermore, the modified mobile phase improved the retention of muraglitazar, a hydrophobic compound, on the normal phase silica column. The validation results demonstrated that this method was rugged and suitable for analyzing muraglitazar in human plasma. In comparison with a revised-phase LC/MS/MS method, this single-pot LLE, HILIC/MS/MS method improved the detection sensitivity by more than four-fold based upon the LLOQ signal to noise ratio. This approach may be applied to other hydrophobic compounds with proper modification of the mobile phase compositions. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:979 / 988
页数:10
相关论文
共 33 条
[1]   Determination of olanzapine in human blood by liquid chromatography-tandem mass spectrometry [J].
Berna, A ;
Ackermann, B ;
Ruterbories, K ;
Glass, S .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 767 (01) :163-168
[2]   Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: A retrospective review of randomly selected medical records [J].
Boyle, PJ ;
King, AB ;
Olansky, L ;
Marchetti, A ;
Lau, H ;
Magar, R ;
Martin, J .
CLINICAL THERAPEUTICS, 2002, 24 (03) :378-396
[3]   Hydrophilic interaction liquid chromatography/electrospray mass spectrometry determination of acyclovir in pregnant rat plasma and tissues [J].
Brown, SD ;
White, CA ;
Bartlett, MG .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2002, 16 (19) :1871-1876
[4]   Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [muraglitazar BMS-298585], a novel peroxisome proliferator-activated receptor α/γ dual agonist with efficacious glucose and lipid-lowering activities [J].
Devasthale, PV ;
Chen, S ;
Jeon, Y ;
Qu, FC ;
Shao, CN ;
Wang, W ;
Zhang, H ;
Cap, M ;
Farrelly, D ;
Golla, R ;
Grover, G ;
Harrity, T ;
Ma, ZP ;
Moore, L ;
Ren, J ;
Seethala, R ;
Cheng, L ;
Sleph, P ;
Sun, W ;
Tieman, A ;
Wetterau, JR ;
Doweyko, A ;
Chandrasena, G ;
Chang, SY ;
Humphreys, WG ;
Sasseville, VG ;
Biller, SA ;
Ryono, DE ;
Selan, F ;
Hariharan, N ;
Cheng, PTW .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) :2248-2250
[5]   Evaluation of ethoxynonafluorobutane as a safe and environmentally friendly solvent for chiral normal-phase LC-atmospheric pressure chemical ionization/electrospray ionization-mass spectrometry [J].
Ding, J ;
Desai, M ;
Armstrong, DW .
JOURNAL OF CHROMATOGRAPHY A, 2005, 1076 (1-2) :34-43
[6]   Liquid/liquid extraction using 96-well plate format in conjunction with hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the analysis of fluconazole in human plasma [J].
Eerkes, A ;
Shou, WZ ;
Weng, ND .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (05) :917-928
[7]   Simultaneous assay of sildenafil and desmethylsildenafil in human plasma using liquid chromatography-tandem mass spectrometry on silica column with aqueous-organic mobile phase [J].
Eerkes, A ;
Addison, T ;
Weng, ND .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 768 (02) :277-284
[8]  
*FOOD DRUG ADM CDE, 2001, GUID IND BIOAN METH
[9]  
INES PT, 1999, CURR OPIN LIPIDOL, V10, P151
[10]   Direct injection of solid-phase extraction eluents onto silica columns for the analysis of polar compounds isoniazid and cetirizine in plasma using hydrophilic interaction chromatography with tandem mass spectrometry [J].
Li, AC ;
Junga, H ;
Shou, WZ ;
Bryant, MS ;
Jiang, XY ;
Weng, ND .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2004, 18 (19) :2343-2350